Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Motzer, R. J.; Barrios, C. H.; Kim, T. M.; Falcon, S.; Cosgriff, T.; Harker, W. G.; Pittman, K. B.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; Page, R. D.; Bavbek, S. E.; Beck, J. T.; Patel, P. M.; Schiff, E.; Vaury, A.; Niolat, J.; Gogov, S.; Anak, O.; Knox, J. |
| Abstract Title: | Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419601520 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.4504 |
| Notes: | Meeting Abstract: 4504 -- Source: Wos |
